41O Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Outlook Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.847 EUR -0.35% Market Closed

Market Cap: €37.6m

	Outlook Therapeutics Inc F:41O	US
A	Avient Corp XMUN:PY9	US
M	Major Cineplex Group PCL SET:MAJOR	TH
S	Schroders PLC F:PYX	UK
C	CenterPoint Energy Inc F:HOU	US
	NanoViricides Inc F:NV3P	US
	Lamda Development SA LSE:0NCY	GR
	Beowulf Mining PLC LSE:BEM	UK
B	BAWAG Group AG OTC:BWAGF	AT

Profitability Summary

Outlook Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-46%

Negative 3Y Average Gross Margin

-7%

Negative Operating Margin

-14.256%

Negative 3Y Average Operating Margin

-10.909%

Negative Net Margin

-14.346%

Negative 3Y Average Net Margin

-14.056%

Negative Free Cash Flow Margin

-11.072%

Negative 3Y Average Free Cash Flow Margin

-9.308%

Exceptional ROE

198%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-2.156%

Declining ROIC

-693% > -2.843%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.